調剤支援用シロップ剤データベースの作成とその試用
スポンサーリンク
概要
- 論文の詳細を見る
We prepared a database (689 KB) on 113 medicated syrups using Microsoft Access to quickly search information primarily concerning potential incompatibilities when dispensing medicated syrups. This database contains and allows access to data concerning 16 items such as trade names, compositions, additives, incompatibilities, and the recommended doses collected from interview forms, package inserts, in-housedocuments, and from the literature. It can also accurately calculate the pediatric dose based on the adult dose. The size of this database is 906 KB including the basic data of Microsoft Excel (226 KB) prepared for facilities that do not possess Micro-soft Access so that the entire database can be used as a simple database that utilizes the filter function of Microsoft Excel and, with file conversion, can also be used on Windows CE and Macintosh systems. Moreover, these basic data are also available to a large number of people via the LAN and Internet when converted to FileMaker Pro 5. As a result of the use of this database, a mean of 0.9 cases of absolute incompatibilities and a mean of 1.8 cases of possible incompatibilities per item were revealed in the 113 items, and 64 items were found to contain phydroxybenzoic esters as additives, which have been suggested to have a possible side effect of inducing asthma attacks. The data on the dosage for children were missing in 26 items (about 23%). Furthermore, we investigated the rate of prescriptions including medicated syrups at two pharmacies. The rates at pharmacy A and B were about 11% and 2%, respectively. Thirty four % and 82% of the prescribed medicines included medicated syrups at pharmacy A and B. Sixty three % of the prescriptions for pediatrics patients included 3 or more medicated syrups. This database is thus considered to be useful for both preparing and evaluating prescriptions for medicated syrups, their dispensing, and also as a source for educating patients.
- 日本医療薬学会の論文
- 2000-12-10
著者
関連論文
- O-14 モルモット摘出心臓を用いた抗マラリア薬による QT 延長作用の比較
- 30-H-12 軟膏中薬物の皮膚移行性に対する各種基剤の影響(品質管理、製剤試験,医療薬学の扉は開かれた)
- Comparison of drug prices between extracts and decoctions of Chinese medicine as ethical pharmaceuticals considering dispensing free and contents of index ingredients
- Development of a Computer Aided Information System to Provide Information of Adverse Effects to the Patient
- Current Situation of the Additional Severe Adverse Effects of Marketed Medicine
- 6年制薬学部の効果的な長期実務実習実施に関する検討
- 医薬品画像を載せた薬袋の調剤過誤防止ツールとしての評価
- CYP2Cl9遺伝子多型とプロトンポンプ阻害剤の体内動態・除菌治療効果との関連性
- 副作用情報提供支援プログラムの構築
- 医薬品市販後に追加される重大な副作用の現状
- 01P3-104 実務実習に必要な情報検索ツールに関する検討 : 小規模病院の場合(薬学教育・生涯教育(認定),医療薬学の扉は開かれた)
- Overlapping of the Clinically Significant Adverse Reactions of Drugs in the Poly-pharmacy
- 薬物体液中濃度測定指針作成(病院薬局協議会)
- B-17 ラットにおけるシクロスポリンの体内動態に及ぼすクラリスロマイシンの影響
- P20 シクロスポリンの体内動態と胃排出速度 : ラット消化管吸収に及ぼすアトロピンの影響
- Hep G2 細胞におけるCiclosporin併用によるPrednisoloneのCYP3A4誘導効果の検討
- TDX,IMXによる血中ジゴキシン濃度測定における問題点
- ペプチド性医薬品の安定化, 持続化を目的とした皮下投与剤形の開発 : 薬剤の有効な投与方法に関する研究
- Distribution and Metabolism of [Asu^]-Eel Calcitonin in Isolated Perfused Rat Pancreas
- 多剤併用処方にみられる重大な副作用重複の現状
- 調剤支援用シロップ剤データベースの作成とその試用
- Comparative Study of Superoxide Dismutase in Normal and HereditaryCataract (UPL) Rats
- 調剤支援用シロップ剤データベースの作成とその試用
- Induction of CYP3As in HepG2 Cells by Several Drugs. - Association between Induction of CYP3A4 and Expression of Glucocorticoid Receptor -.
- A survey on pharmaceutical information in daily newspapers
- Analysis of Body Constitution of Fifty-two Patients with Stevens-Johnson Syndrome (SJS) Using Kampo Medical Questionnaires: Prediction of SJS based on Body Constitution Using Decision Tree
- Adrenergic Receptor Genotype-Related Changes in cAMPLevels in peripheral Blood Mononuclear Cells after Multiple-Dose Oral Procaterol
- CYP2C19 Genotype Related Effect of Omeprazole onIntragastric pH and Antimicrobial Stability
- Identification of N-Acetyltransferase 2 and CYP2C19Genotypes for Hair, Buccal Cell Swabs, or Fingernails Comparedwith Blood
- N-Acetyltransferase2 Genotype Correlated with IsoniazidAcetylation in Japanese Tuberculous Patients
- Nicardipine and Itraconazole Inhibited Transcellular Transport of Digoxin.
- The Novel Anticancer Drug KRN5500 Interacts with, but is HardlyTransported by, Human P-Glycoprotein
- Sufficient Effect of 1-week Omeprazole and Amoxicillin DualTreatment for Helicobacter Pylori Eradication in CytochromeP-450 2C19 poor Metabolizers
- CYP2C19 Genotype-related Efficacy of Omeprazole forThe Treatment of Infection Caused by Helicobacter pylori
- Interaction of Docetaxel ("Taxotere") with Human P-Glycoprotein
- Cellular Pharmacokinetic Aspects of Reversal Effects ofItraconazole on P-Glycoprotein- Mediated ResistanceAnticancer Drugs
- Effect of Secretable SOD Delivered by Genetically ModifiedCells on Xanthine/xanthine Oxidase and Paraquat - InducedCytotoxicity in Vitro
- 生理活性蛋白およびペプチド性医薬品